Innova Captab vs Peers
- Market cap
- ₹6,378 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹802.44 – ₹1,504.58
Innova Captab ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Innova Captab. Its P/E of 22.5 compares with a peer median of 22.5.
Innova Captab vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Innova Captab | 1,114.50 | -1.33% | 6,378 | 22.5 | 2.85 | 14.5% | +18.5% |
| Innova Captab | 1,114.50 | -1.33% | 6,378 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Innova Captab peer comparison — frequently asked questions
Who are Innova Captab's competitors?
Innova Captab's listed peers in Drug Manufacturers - Specialty & Generic include Innova Captab, ranked here by market capitalisation.
How does Innova Captab's P/E compare with its peers?
Innova Captab trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Innova Captab's peers?
By market capitalisation, the largest company in the group is Innova Captab at ₹6,378 crore, against ₹6,378 crore for Innova Captab.
Same Data For Peers
Trade Innova Captab With ATS
Track INNOVACAP live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.